167 related articles for article (PubMed ID: 36712981)
1. Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity.
Kawall A; Lewis DSM; Sharma A; Chavada K; Deshmukh R; Rayalam S; Mody V; Taval S
Front Chem; 2022; 10():1100460. PubMed ID: 36712981
[TBL] [Abstract][Full Text] [Related]
2. Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro.
Lewis DSM; Ho J; Wills S; Kawall A; Sharma A; Chavada K; Ebert MCCJC; Evoli S; Singh A; Rayalam S; Mody V; Taval S
Sci Rep; 2022 Feb; 12(1):2145. PubMed ID: 35140265
[TBL] [Abstract][Full Text] [Related]
3. Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study.
Gogoi M; Borkotoky M; Borchetia S; Chowdhury P; Mahanta S; Barooah AK
J Biomol Struct Dyn; 2022 Sep; 40(15):7143-7166. PubMed ID: 33715595
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z
J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Ubiquitin and ISG15 Deconjugase Activity of SARS-CoV-1 and SARS-CoV-2 Papain-Like Protease.
Nayak D; Dos Santos Bury P; Drag M; Nijkerk AN; El Oualid F; Olsen SK
Methods Mol Biol; 2023; 2591():171-188. PubMed ID: 36350549
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo.
van Huizen M; Bloeme-Ter Horst JR; de Gruyter HLM; Geurink PP; van der Heden van Noort GJ; Knaap RCM; Nelemans T; Ogando NS; Leijs AA; Urakova N; Mark BL; Snijder EJ; Myeni SK; Kikkert M
PLoS Pathog; 2024 Mar; 20(3):e1012100. PubMed ID: 38527094
[TBL] [Abstract][Full Text] [Related]
8. Potent, Novel SARS-CoV-2 PLpro Inhibitors Block Viral Replication in Monkey and Human Cell Cultures.
Shen Z; Ratia K; Cooper L; Kong D; Lee H; Kwon Y; Li Y; Alqarni S; Huang F; Dubrovskyi O; Rong L; Thatcher GR; Xiong R
bioRxiv; 2021 Feb; ():. PubMed ID: 33594371
[TBL] [Abstract][Full Text] [Related]
9. Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: an in silico approach to combat COVID-19.
Swargiary A; Mahmud S; Saleh MA
J Biomol Struct Dyn; 2022 Mar; 40(5):2067-2081. PubMed ID: 33089730
[TBL] [Abstract][Full Text] [Related]
10. Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-CoV-2 PLpro.
Liu X; Zheng M; Zhang H; Feng B; Li J; Zhang Y; Zhang J; Zhao N; Li C; Song N; Song B; Yang D; Chen J; Qi A; Zhao L; Luo C; Zang Y; Liu H; Li J; Zhang B; Zhou Y; Zheng J
Antiviral Res; 2024 Jun; ():105944. PubMed ID: 38914283
[TBL] [Abstract][Full Text] [Related]
11. Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2.
Waqas M; Ullah S; Halim SA; Rehman NU; Ali A; Jan A; Muhsinah AB; Khan A; Al-Harrasi A
Int J Biol Macromol; 2024 Feb; 258(Pt 1):128812. PubMed ID: 38114011
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of senkyuchachosan on SARS-CoV-2 papain-like protease activity in vitro.
Kiba Y; Tanikawa T; Hayashi T; Yokogawa T; Sano A; Suzuki R; Kitamura M
J Nat Med; 2024 Jun; 78(3):784-791. PubMed ID: 38512650
[TBL] [Abstract][Full Text] [Related]
13. In-silico docking studies of selected phytochemicals against papain like protease of SARS-Cov-2.
Saranya P; Karunya R; Keerthi Varshini G; Kowsikan K; Prathiksha R
Vegetos; 2023; 36(1):188-194. PubMed ID: 36530568
[TBL] [Abstract][Full Text] [Related]
14. Effective inhibition of coronavirus replication by
Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
[No Abstract] [Full Text] [Related]
15. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
16. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
17. Food phytochemicals, epigallocatechin gallate and myricetin, covalently bind to the active site of the coronavirus main protease
Kato Y; Higashiyama A; Takaoka E; Nishikawa M; Ikushiro S
Adv Redox Res; 2021 Dec; 3():100021. PubMed ID: 35425933
[TBL] [Abstract][Full Text] [Related]
18. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
Báez-Santos YM; St John SE; Mesecar AD
Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of metal ions for COVID-19: insights from the papain-like protease of SARS-CoV-2.
Shetler CL; Ferreira JC; Cardoso THS; Silva EMA; Saksena NK; Rabeh WM
Biochem J; 2022 Oct; 479(20):2175-2193. PubMed ID: 36205308
[TBL] [Abstract][Full Text] [Related]
20. A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2.
Singh E; Jha RK; Khan RJ; Kumar A; Jain M; Muthukumaran J; Singh AK
Comput Biol Chem; 2022 Aug; 99():107721. PubMed ID: 35835027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
